TRDA · Company research
Entrada Therapeutics, Inc. Common Stock (TRDA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| What's Going On With Entrada Therapeutics Stock Wednesday? - Benzinga | What's Going On With Entrada Therapeutics Stock Wednesday? Benzinga | View source ↗ | Benzinga | Oct 14, 2026 | neutral | 0 | 0.6 |
| (TRDA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily | (TRDA) Movement Within Algorithmic Entry Frameworks Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 14, 2026 | neutral | 0 | 0.6 |
| A Duchenne treatment study may test its highest dose yet. One group's data are expected by year-end. - Stock Titan | A Duchenne treatment study may test its highest dose yet. One group's data are expected by year-end. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| An experimental Duchenne treatment showed a muscle-protein increase and could be given about nine times a year. - Stock Titan | An experimental Duchenne treatment showed a muscle-protein increase and could be given about nine times a year. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| $TRDA stock is down 10% today. Here's what we see in our data. - Quiver Quantitative | $TRDA stock is down 10% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 1, 2026 | neutral | 0 | 0.6 |
| Institutional holder sells Entrada (NASDAQ: TRDA) shares over three days - Stock Titan | Institutional holder sells Entrada (NASDAQ: TRDA) shares over three days Stock Titan | View source ↗ | Stock Titan | Sep 3, 2026 | neutral | 0 | 0.6 |
| Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance | Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Tops Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 5, 2026 | neutral | 0 | 0.6 |
| 5am Ventures V sells $807,027 of Entrada Therapeutics stock - Investing.com | 5am Ventures V sells $807,027 of Entrada Therapeutics stock Investing.com | View source ↗ | Investing.com | Aug 4, 2026 | neutral | 0 | 0.6 |
| $TRDA stock is up 14% today. Here's what we see in our data. - Quiver Quantitative | $TRDA stock is up 14% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 29, 2026 | neutral | 0 | 0.6 |
| TRDA Forecast — Price Target — Prediction for 2027 - TradingView | TRDA Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| TRDA - Entrada Therapeutics Inc Stock Price and Quote - Finviz | TRDA - Entrada Therapeutics Inc Stock Price and Quote Finviz | View source ↗ | Finviz | May 26, 2026 | neutral | 0 | 0.6 |
| Entrada Therapeutics (TRDA) Q1 Revenue Slump Tests High Growth Narratives - Simply Wall Street | Entrada Therapeutics (TRDA) Q1 Revenue Slump Tests High Growth Narratives Simply Wall Street | View source ↗ | Simply Wall Street | May 8, 2026 | neutral | 0 | 0.6 |
| Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance | Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | May 7, 2026 | neutral | 0 | 0.6 |
| Entrada plunges on trial data for Duchenne drug (TRDA:NASDAQ) - Seeking Alpha | Entrada plunges on trial data for Duchenne drug (TRDA:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | May 7, 2026 | neutral | 0 | 0.6 |
| Market Movers | Winners: BNZI, OLOX, AGL | Losers: GDC, ENGN, TRDA - Trefis | Market Movers | Winners: BNZI, OLOX, AGL | Losers: GDC, ENGN, TRDA Trefis | View source ↗ | Trefis | May 7, 2026 | neutral | 0 | 0.6 |
| Entrada: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts (NASDAQ:TRDA) - Seeking Alpha | Entrada: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts (NASDAQ:TRDA) Seeking Alpha | View source ↗ | Seeking Alpha | Nov 17, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.